Shenzhen Mindray Bio-Medic-A
13F holders, Q3 2025 (September 30)1holders
0new positions
0sold out
$34.47avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Shenzhen Mindray Bio-Medic-A in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holder was Boston Common Asset Management, LLC ($6.2M).
- Company
- Shenzhen Mindray Bio-Medic-A
- CUSIP
- Y774E3101
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 5,700 shares sold, net −5,700 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Boston Common Asset Management, LLC | 0.17% | Reduce -3.1% | 180,740 | $6.2M |
"% of holder's portfolio" is SHENZHEN MINDRAY BIO-MEDIC-A's weight in each manager's 13F, not the share of Shenzhen Mindray Bio-Medic-A the manager owns.